In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs - STAT

In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs - STAT
Business

Listen to this article

0%

AstraZeneca on Friday detailed the surprise failure of a closely watched heart disease clinical trial, laying out how its experimental drug offered no additional benefits for patients who were largel… [+1099 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected